In the present study, TF+ MPs were also over-expressed in colon cancer stage I. This augment may at least in part due to colon cancer-derived TF+ MPs, since tumor-derived MPs are critical sources of TF in cancer and human TF antigen has been demonstrated to be released into the blood from human colon tumor [17, 45, 46]. This evidence concerns the gene TF and colonic neoplasm.